Captor Therapeutics S.A. (CTX) — Cash Flow Reinvestment Rate
Captor Therapeutics S.A. (CTX) has a Cash Flow Reinvestment Rate of 1.94x as of March 2025, reinvesting zł44.69 Million (capex zł83.00K plus investments zł-44.60 Million) from operating cash flow of zł23.06 Million. Explore CTX capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Captor Therapeutics S.A. Cash Flow Reinvestment Rate (2017–2019)
Historical reinvestment intensity for Captor Therapeutics S.A. across 2 annual periods. Also explore Captor Therapeutics S.A. assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Captor Therapeutics S.A. (2017–2019)
Year-by-year capital reinvestment analysis for Captor Therapeutics S.A.. For live market cap and broader valuation context, see Captor Therapeutics S.A. market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (PLN) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 0.10x | zł460.00K | zł4.39 Million | zł229.00K | — |
| 2017 | 0.00x | zł0.00 | zł2.10 Million | zł0.00 | — |